NCT03059082

Brief Summary

Excessive alcohol consumption is common in patients admitted to the intensive care unit (ICU). Among patients who survive an ICU admission, excessive alcohol consumption is associated with a higher risk of being admitted the hospital. In this study, the Investigators will compare an intervention designed to address excessive drinking in ICU survivors to usual care. This intervention combines motivational interviewing (MI) and shared decision making (SDM). MI and SDM share several core components including the development of a therapeutic alliance and promotion of autonomy. MI can be employed in the context of motivating a patient to change their drinking. Once this decision has been made, SDM can be employed to help a patient decide amongst multiple reasonable treatment options. The Investigators long-term goal is to test whether MI-SDM is better than usual care and whether multiple sessions of MI-SDM are better than a single session. This pilot clinical trial will demonstrate the feasibility of conducting a larger efficacy study to test these hypotheses.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2016

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 3, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 23, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2018

Completed
Last Updated

November 21, 2019

Status Verified

November 1, 2019

Enrollment Period

1.7 years

First QC Date

January 3, 2017

Last Update Submit

November 19, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Client Satisfaction and Acceptability of study

    Client satisfaction questionnaire (CSQ-8), with revisions to make it specific to the objectives of this study.

    6 months

Secondary Outcomes (20)

  • Subject Recruitment Rate

    6 months

  • Subject willingness to be randomized

    6 months

  • Subject Dropout Rates

    3 and 6 months

  • Subjects with at least one visit after discharge

    6 months

  • Time per subject visit

    6 months

  • +15 more secondary outcomes

Study Arms (3)

Continued Interaction

OTHER

This group will undergo contact with Recovery Navigator on an "as needed basis" up to 6 months.They will then have a 3 month and 6 month follow up visit with the PI. There is no drug or treatment administered to the subject. The intervention is the conversation/contact with the Recovery Navigator, in this arm, it is continued throughout the study. Note: The first 10 subjects will not be randomized and will be assigned to this Arm. The purpose of this is to ensure the fidelity of the intervention. The remaining 60 subjects will be randomized equally among the three Arms. Data from the first 10 subjects will not be considered for the outcome measures.

Behavioral: Recovery Navigator on an as needed basis up to 6 months

Single interaction

OTHER

This group will undergo one interaction with the Recovery Navigator prior to the hospital discharge. They will then have a 3 month and 6 month follow up visit with the PI. There is no drug or treatment administered to the subject.The intervention is the conversation/contact with the Recovery Navigator, in this arm, it is conducted once.

Behavioral: Recovery Navigator prior to hospital discharge

Control

OTHER

This group will not have any interaction with the Recovery Navigator. They will then have a 3 month and 6 month follow up visit. There is no drug or treatment administered to the subject.

Other: No interaction with Recovery Navigator

Interventions

This group will undergo contact with Recovery Navigator on an "as needed basis" up to 6 months and then have a 3 month and 6 month follow-up visit.

Also known as: Recovery Navigator
Continued Interaction

This group will undergo one interaction with Recovery Navigator prior to hospital discharge and then have a 3 month and 6 month follow-up visit.

Also known as: Recovery Navigator
Single interaction

This group will not have any interaction with Recovery Navigator. They will have a 3 month and 6 month follow-up visit.

Also known as: Control
Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Admission to the intensive care unit;
  • Age 18 years or older;
  • Resolution of critical illness, defined as the intention of the treating team to discharge the patient or downgrade their admission level from the ICU to a progressive care unit or the floor;
  • Resolution of delirium, defined by:
  • a Riker Agitation Sedation Scale score of 0,
  • a negative CAM ICU, and
  • confirmation from the treating team (nurse, physicians) that the patient is not delirious.
  • AUDIT-C score of 3 or greater for women and 4 or greater for men.

You may not qualify if:

  • Prisoner;
  • Pregnant;
  • Unable to speak or write in English;
  • Unable to provide informed consent;
  • Unable to provide a home or cell phone number plus at least one additional way to be contacted (mail, email, friend or family);
  • Expected survival less than 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado

Aurora, Colorado, 80045, United States

Location

MeSH Terms

Conditions

Alcoholism

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Brendan J Clark, MD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 3, 2017

First Posted

February 23, 2017

Study Start

December 1, 2016

Primary Completion

August 31, 2018

Study Completion

August 31, 2018

Last Updated

November 21, 2019

Record last verified: 2019-11

Locations